NovaSure is a device for endometrial ablation, which is a procedure that removes the endometrium, that the US Food and Drug Administration, or FDA, approved for use on 28 September 2001. Endometrium is the tissue that lines the uterus. NovaSure destroys the endometrium by sending electric beams at the endometrium. Hologic, a medical technology company concerned with women’s health, developed NovaSure to treat menorrhagia, or heavy bleeding during menstruation. Menorrhagia is a common symptom of endometriosis. Endometriosis is the growth of the endometrium outside of the uterus. While NovaSure is not a treatment that doctors use to directly treat endometriosis, the procedure may help alleviate heavy bleeding during menstruation, which may improve a patient’s quality of life as heavy menstrual bleeding is often associated with high levels of anxiety and low levels of confidence.

In the 1960s in the United States Landrum B. Shettles developed the Shettles method, which is a procedure for couples to use prior to and during an intercourse to increase their chances of conceiving a fetus of their desired sex. Shettles, a physician, who specialized in obstetrics and gynecology, found a difference in the size and shape of male sperm cells that he correlated with the different sex chromosomes they carry. Based on that finding, Shettles developed procedures for couples to follow based on whether they desire a female or a male fetus and published them in the 1970 book, Your Baby’s Sex: Now You Can Choose. The Shettles method is based on the idea that male-producing sperm prefer alkaline conditions, whereas female-producing sperm prefer acidic conditions. The method provides couples with a procedure intended to enhance the favored environment for the sperm that will supposedly produce the desired sex, including female douches to be used before intercourse and how to time sexual intercourse within the female menstrual cycle. The book Your Baby’s Sex: Now You Can Choose, made the Shettles method a widely popular method of natural sex selection.

The first successful cloning of a gaur in 2000 by Advanced Cell Technology involved the cells of two animals: an egg cell from a domestic cow and a skin cell from a gaur. The researchers extracted the egg cell from the ovary of the domestic cow and the skin cell from the skin of the gaur. First, the researchers performed nuclear transplantation on the egg cell of the cow, during which they removed the nucleus of the egg cell. The mitochondria of the egg cell remained intact inside the cell. Next, the researchers fused the egg cell of the cow and the skin cell of the gaur by applying a single electric pulse. That process resulted in a cellular complex that contained the nucleus from the gaur and the mitochondria from the cow. That cellular complex was then placed into the uterus of a different domestic cow. Once the cellular complex developed into a Day 46 fetus, researchers conducted morphological and genetic tests. The fetus then further developed into a gaur calf, which lived for forty-eight hours after birth.